Literature DB >> 10807023

Identifying meaningful intra-individual change standards for health-related quality of life measures.

K W Wyrwich1, F D Wolinsky.   

Abstract

Although numerous measures have been developed for the evaluation of health-related quality of life (HRQoL), strategies for identifying meaningful intra-individual change in these measures have not kept pace with instrument development. As a result, clinical trial researchers, quality assurance assessment teams and practising clinicians are without established standards to evaluate individual patient change in HRQoL measures as improved, stable or declined. This article reviews and critiques the methods that have been applied to establish intra-individual HRQoL change standards. These methods include within-person and between-persons anchor-based studies, as well as distribution-based techniques using the effect size, the standard error of measurement, the mean squared error or individual slope coefficients derived from hierarchical linear modelling. Practical approaches to improving and advancing HRQoL change evaluations that enhance the interpretation of intra-individual change are provided. Two future methodological challenges in this area of HRQoL research are examined: (1) the development of individual change standards for generic HRQoL measures; and (2) the incorporation of individual clinical assessments into the process for establishing significant intra-individual change standards.

Entities:  

Mesh:

Year:  2000        PMID: 10807023     DOI: 10.1046/j.1365-2753.2000.00238.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  58 in total

1.  Typical error versus limits of agreement.

Authors:  G Atkinson; A Nevill
Journal:  Sports Med       Date:  2000-11       Impact factor: 11.136

2.  Comparison of reliability and responsiveness of patient-reported clinical outcome measures in knee osteoarthritis rehabilitation.

Authors:  Valerie J Williams; Sara R Piva; James J Irrgang; Chad Crossley; G Kelley Fitzgerald
Journal:  J Orthop Sports Phys Ther       Date:  2012-03-08       Impact factor: 4.751

3.  Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.

Authors:  Robert J Ferguson; Amy B Robinson; Mark Splaine
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

Review 4.  A blueprint for symptom scales and responses: measurement and reporting.

Authors:  K W Wyrwich; V M Staebler Tardino
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 5.  Quality of life in older people: a structured review of generic self-assessed health instruments.

Authors:  K L Haywood; A M Garratt; R Fitzpatrick
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

6.  Estimating clinically significant differences in quality of life outcomes.

Authors:  Kathleen W Wyrwich; Monika Bullinger; Neil Aaronson; Ron D Hays; Donald L Patrick; Tara Symonds
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

7.  Measuring clinically meaningful change following mental health treatment.

Authors:  Susan V Eisen; Gayatri Ranganathan; Pradipta Seal; Avron Spiro
Journal:  J Behav Health Serv Res       Date:  2007-05-30       Impact factor: 1.505

8.  Triangulating patient and clinician perspectives on clinically important differences in health-related quality of life among patients with heart disease.

Authors:  Kathleen W Wyrwich; Stacie M Metz; Kurt Kroenke; William M Tierney; Ajit N Babu; Fredric D Wolinsky
Journal:  Health Serv Res       Date:  2007-12       Impact factor: 3.402

9.  Reply to minimal clinically important difference and Edmonton Symptom Assessment Scale.

Authors:  David Hui; Eduardo Bruera
Journal:  Cancer       Date:  2015-09-18       Impact factor: 6.860

10.  Effects of colpocleisis on bowel symptoms among women with severe pelvic organ prolapse.

Authors:  Robert E Gutman; Catherine S Bradley; Wen Ye; Alayne D Markland; William E Whitehead; Mary P Fitzgerald
Journal:  Int Urogynecol J       Date:  2009-12-04       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.